These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 21497898)

  • 1. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.
    Marshall BD; Milloy MJ; Wood E; Montaner JS; Kerr T
    Lancet; 2011 Apr; 377(9775):1429-37. PubMed ID: 21497898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
    Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
    PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do supervised injecting facilities attract higher-risk injection drug users?
    Wood E; Tyndall MW; Li K; Lloyd-Smith E; Small W; Montaner JS; Kerr T
    Am J Prev Med; 2005 Aug; 29(2):126-30. PubMed ID: 16005809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for evaluating North America's first medically supervised safer-injecting facility.
    Wood E; Kerr T; Montaner JS; Strathdee SA; Wodak A; Hankins CA; Schechter MT; Tyndall MW
    Lancet Infect Dis; 2004 May; 4(5):301-6. PubMed ID: 15120347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated drug overdose deaths averted by North America's first medically-supervised safer injection facility.
    Milloy MJ; Kerr T; Tyndall M; Montaner J; Wood E
    PLoS One; 2008 Oct; 3(10):e3351. PubMed ID: 18839040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility.
    Wood E; Tyndall MW; Qui Z; Zhang R; Montaner JS; Kerr T
    Am J Public Health; 2006 May; 96(5):770-3. PubMed ID: 16571703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a medically supervised injection facility among street youth.
    Hadland SE; DeBeck K; Kerr T; Nguyen P; Simo A; Montaner JS; Wood E
    J Adolesc Health; 2014 Nov; 55(5):684-9. PubMed ID: 24925493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime.
    Wood E; Tyndall MW; Lai C; Montaner JS; Kerr T
    Subst Abuse Treat Prev Policy; 2006 May; 1():13. PubMed ID: 16722550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
    Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
    Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
    Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
    Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
    Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E
    Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
    Salmon AM; van Beek I; Amin J; Kaldor J; Maher L
    Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.
    Milloy MJ; Kerr T; Mathias R; Zhang R; Montaner JS; Tyndall M; Wood E
    Am J Drug Alcohol Abuse; 2008; 34(4):499-509. PubMed ID: 18584579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding supervised injection facilities across Canada: lessons from the Vancouver experience.
    Young S; Fairbairn N
    Can J Public Health; 2018 Apr; 109(2):227-230. PubMed ID: 29981039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.
    Bouvier BA; Elston B; Hadland SE; Green TC; Marshall BD
    Harm Reduct J; 2017 Feb; 14(1):13. PubMed ID: 28219388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.
    Kerr T; Stoltz JA; Tyndall M; Li K; Zhang R; Montaner J; Wood E
    BMJ; 2006 Jan; 332(7535):220-2. PubMed ID: 16439401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
    Notta D; Black B; Chu T; Joe R; Lysyshyn M
    Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility.
    Fairbairn N; Small W; Shannon K; Wood E; Kerr T
    Soc Sci Med; 2008 Sep; 67(5):817-23. PubMed ID: 18562065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safe injection facilities save lives.
    Beyrer C
    Lancet; 2011 Apr; 377(9775):1385-6. PubMed ID: 21497899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.